Press "Enter" to skip to content

FDA permits marketing of first medical device for relief of pain associated with irritable bowel syndrome in patients 11-18 years of age

FDA permits marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome (IBS) when combined with other therapies for IBS.

Original source:

Also Read:   Statement on new steps to advance innovation in medical device sterilization with ethylene oxide